DE60209757D1 - Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycin - Google Patents
Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycinInfo
- Publication number
- DE60209757D1 DE60209757D1 DE60209757T DE60209757T DE60209757D1 DE 60209757 D1 DE60209757 D1 DE 60209757D1 DE 60209757 T DE60209757 T DE 60209757T DE 60209757 T DE60209757 T DE 60209757T DE 60209757 D1 DE60209757 D1 DE 60209757D1
- Authority
- DE
- Germany
- Prior art keywords
- breast
- prostate
- dimethylglycin
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 title abstract 3
- 210000000481 breast Anatomy 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 210000002307 prostate Anatomy 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 108700003601 dimethylglycine Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US838571 | 1986-03-11 | ||
| US83857101A | 2001-04-20 | 2001-04-20 | |
| PCT/US2002/012425 WO2002085345A1 (en) | 2001-04-20 | 2002-04-19 | Method of preventing or treating breast, prostate and/or cervical cancer with n,n-dimethylglycine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60209757D1 true DE60209757D1 (de) | 2006-05-04 |
| DE60209757T2 DE60209757T2 (de) | 2006-11-23 |
Family
ID=25277454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60209757T Expired - Fee Related DE60209757T2 (de) | 2001-04-20 | 2002-04-19 | Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycin |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1385497B1 (de) |
| AT (1) | ATE319443T1 (de) |
| CA (1) | CA2444745A1 (de) |
| DE (1) | DE60209757T2 (de) |
| DK (1) | DK1385497T3 (de) |
| WO (1) | WO2002085345A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4385068A (en) * | 1980-03-10 | 1983-05-24 | Davinci Laboratories, A Division Of Food Science Corporation | N,N-Dimethylglycine and use in immune response |
| US4994492A (en) * | 1989-01-09 | 1991-02-19 | Foodscience Corporation | Treatment of melanoma using N,N-dimethylglycine |
| US5026728A (en) * | 1989-10-05 | 1991-06-25 | Foodscience Corporation | Treatment of arthritis and inflammation using N,N-dimethylglycine |
-
2002
- 2002-04-19 EP EP02764251A patent/EP1385497B1/de not_active Expired - Lifetime
- 2002-04-19 DK DK02764251T patent/DK1385497T3/da active
- 2002-04-19 CA CA002444745A patent/CA2444745A1/en not_active Abandoned
- 2002-04-19 AT AT02764251T patent/ATE319443T1/de not_active IP Right Cessation
- 2002-04-19 WO PCT/US2002/012425 patent/WO2002085345A1/en not_active Application Discontinuation
- 2002-04-19 DE DE60209757T patent/DE60209757T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1385497A1 (de) | 2004-02-04 |
| DE60209757T2 (de) | 2006-11-23 |
| DK1385497T3 (da) | 2006-07-17 |
| ATE319443T1 (de) | 2006-03-15 |
| EP1385497A4 (de) | 2005-06-08 |
| WO2002085345A1 (en) | 2002-10-31 |
| EP1385497B1 (de) | 2006-03-08 |
| CA2444745A1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023476D1 (de) | Kombination von doctaxel und rhumab her2 zür krebsbehandlung | |
| DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
| ATE305300T1 (de) | Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren | |
| ATE551996T1 (de) | Behandlung oder prävention von diabetes mit cannabidiol | |
| CZ2000531A3 (en) | Method of prevention or therapy of estrogen-dependent diseases and disorders | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| NO20032027D0 (no) | Effektive antitumorbehandlinger | |
| MXPA04004355A (es) | Tratamiento de combinacion que comprende zd6474 y un taxano. | |
| MY146533A (en) | Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer | |
| BR0207443A (pt) | Método e forma de dosagem para o tratamento de tumores pela administração de tegafur, uracila, ácido folìnico, paclitaxel e carboplatina | |
| DK1689404T3 (da) | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer | |
| ATE447426T1 (de) | Elektromagnetische stimulation bei patienten mit osteoporose | |
| HUP0401913A2 (hu) | Bromhidrosis kezelésére és megelőzésére szolgáló gyógyszerkészítmény | |
| ATE293972T1 (de) | Behandlung von chronischen schmerzen | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE60209757D1 (de) | Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycin | |
| ATE345805T1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
| MXPA03010920A (es) | Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia. | |
| UA32720A (uk) | Спосіб внутрішнього відведення лімфи при мастектомії | |
| UA34375A (uk) | Спосіб лікування рака молочної залози | |
| UA34303A (uk) | Спосіб лікування міокардиту |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |